Clinical trials to exam a new drugs in patients should start as early as 2015.
Existing drugs aim inadequate versions of a protein called BRAF that drives about half of all melanomas, though while primarily really effective, a cancers roughly always turn resistant to diagnosis within a…
New targeted drugs could treat drug-resistant skin cancer
Thursday, December 11, 2014
New targeted drugs could treat drug-resistant skin cancer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment